These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23474049)

  • 21. A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Lin MW; Silvestrini RA; Culican S; Campbell D; Fulcher DA
    Am J Clin Pathol; 2014 Sep; 142(3):325-30. PubMed ID: 25125622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ANCA-associated vasculitis: recent methodological advances for ANCA detection].
    Csernok E
    Dtsch Med Wochenschr; 2018 Apr; 143(7):499-502. PubMed ID: 29614541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application.
    Sinico RA; Radice A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S112-7. PubMed ID: 24854381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
    Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
    PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
    Pollock W; Jovanovich S; Savige J
    J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
    Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
    Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease.
    Trevisin M; Pollock W; Dimech W; Melny J; Paspaliaris B; Gillis D; Wong R; Savige J
    Am J Clin Pathol; 2008 Jan; 129(1):42-53. PubMed ID: 18089488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France].
    Biscay P; Ralazamahaleo M; Lazaro E; Richez C; Seneschal J; Rigothier C; Contin-Bordes C; Duffau P
    Rev Med Interne; 2017 Oct; 38(10):656-662. PubMed ID: 28690094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic vasculitis and the lung.
    Talarico R; Barsotti S; Elefante E; Baldini C; Tani C; Mosca M
    Curr Opin Rheumatol; 2017 Jan; 29(1):45-50. PubMed ID: 27755177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].
    Wada T
    Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes.
    Wiik A
    Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.